Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Consensus Report From the Miami Liver Proton Therapy Conference.

Chuong MD, Kaiser A, Khan F, Parikh P, Ben-Josef E, Crane C, Brunner T, Okumura T, Schreuder N, Bentzen SM, Gutierrez A, Mendez Romero A, Yoon SM, Sharma N, Kim TH, Kishi K, Moeslein F, Hoffe S, Schefter T, Hanish S, Scorsetti M, Apisarnthanarax S.

Front Oncol. 2019 May 31;9:457. doi: 10.3389/fonc.2019.00457. eCollection 2019.

2.

Individualized automated planning for dose bath reduction in robotic radiosurgery for benign tumors.

Rossi L, Méndez Romero A, Milder M, de Klerck E, Breedveld S, Heijmen B.

PLoS One. 2019 Feb 6;14(2):e0210279. doi: 10.1371/journal.pone.0210279. eCollection 2019.

3.

Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.

van Linge A, van Os R, Hoekstra N, Heijmen B, Stienstra L, Dallenga A, Wolbers J, Mendez Romero A.

Radiat Oncol. 2018 Dec 24;13(1):253. doi: 10.1186/s13014-018-1202-z.

4.

Protocol for the STRONG trial: stereotactic body radiation therapy following chemotherapy for unresectable perihilar cholangiocarcinoma, a phase I feasibility study.

Koedijk MS, Heijmen BJM, Groot Koerkamp B, Eskens FALM, Sprengers D, Poley JW, van Gent DC, van der Laan LJW, van der Holt B, Willemssen FEJA, Méndez Romero A.

BMJ Open. 2018 Oct 15;8(10):e020731. doi: 10.1136/bmjopen-2017-020731.

5.

Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus.

Lambrecht M, Eekers DBP, Alapetite C, Burnet NG, Calugaru V, Coremans IEM, Fossati P, Høyer M, Langendijk JA, Méndez Romero A, Paulsen F, Perpar A, Renard L, de Ruysscher D, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Roelofs E, Nyström PW, Troost EGC; work package 1 of the taskforce “European Particle Therapy Network” of ESTRO.

Radiother Oncol. 2018 Jul;128(1):26-36. doi: 10.1016/j.radonc.2018.05.001. Epub 2018 May 17. Review.

PMID:
29779919
6.

An individualized strategy to estimate the effect of deformable registration uncertainty on accumulated dose in the upper abdomen.

Wang Y, Petit SF, Osorio EV, Gupta V, Méndez Romero A, Heijmen B.

Phys Med Biol. 2018 Jun 11;63(12):125005. doi: 10.1088/1361-6560/aac5c2.

PMID:
29771683
7.

The EPTN consensus-based atlas for CT- and MR-based contouring in neuro-oncology.

Eekers DB, In 't Ven L, Roelofs E, Postma A, Alapetite C, Burnet NG, Calugaru V, Compter I, Coremans IEM, Høyer M, Lambrecht M, Nyström PW, Méndez Romero A, Paulsen F, Perpar A, de Ruysscher D, Renard L, Timmermann B, Vitek P, Weber DC, van der Weide HL, Whitfield GA, Wiggenraad R, Troost EGC; “European Particle Therapy Network” of ESTRO.

Radiother Oncol. 2018 Jul;128(1):37-43. doi: 10.1016/j.radonc.2017.12.013. Epub 2018 Mar 13. Review.

8.

Fast and robust adaptation of organs-at-risk delineations from planning scans to match daily anatomy in pre-treatment scans for online-adaptive radiotherapy of abdominal tumors.

Gupta V, Wang Y, Méndez Romero A, Myronenko A, Jordan P, Maurer C, Heijmen B, Hoogeman M.

Radiother Oncol. 2018 May;127(2):332-338. doi: 10.1016/j.radonc.2018.02.014. Epub 2018 Mar 8.

9.

Radiation Dose-Volume Effects for Liver SBRT.

Miften M, Vinogradskiy Y, Moiseenko V, Grimm J, Yorke E, Jackson A, Tomé WA, Ten Haken RK, Ohri N, Méndez Romero A, Goodman KA, Marks LB, Kavanagh B, Dawson LA.

Int J Radiat Oncol Biol Phys. 2018 Jan 6. pii: S0360-3016(17)34527-3. doi: 10.1016/j.ijrobp.2017.12.290. [Epub ahead of print]

PMID:
29482870
10.

Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.

Ohri N, Tomé WA, Méndez Romero A, Miften M, Ten Haken RK, Dawson LA, Grimm J, Yorke E, Jackson A.

Int J Radiat Oncol Biol Phys. 2018 Jan 6. pii: S0360-3016(17)34525-X. doi: 10.1016/j.ijrobp.2017.12.288. [Epub ahead of print]

PMID:
29395629
11.

The TRENDY multi-center randomized trial on hepatocellular carcinoma - Trial QA including automated treatment planning and benchmark-case results.

Habraken SJM, Sharfo AWM, Buijsen J, Verbakel WFAR, Haasbeek CJA, Öllers MC, Westerveld H, van Wieringen N, Reerink O, Seravalli E, Braam PM, Wendling M, Lacornerie T, Mirabel X, Weytjens R, Depuydt L, Tanadini-Lang S, Riesterer O, Haustermans K, Depuydt T, Dwarkasing RS, Willemssen FEJA, Heijmen BJM, Méndez Romero A.

Radiother Oncol. 2017 Dec;125(3):507-513. doi: 10.1016/j.radonc.2017.09.007. Epub 2017 Oct 16.

PMID:
29050954
12.

ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer.

Guckenberger M, Andratschke N, Dieckmann K, Hoogeman MS, Hoyer M, Hurkmans C, Tanadini-Lang S, Lartigau E, Méndez Romero A, Senan S, Verellen D.

Radiother Oncol. 2017 Jul;124(1):11-17. doi: 10.1016/j.radonc.2017.05.012. Epub 2017 Jul 4.

PMID:
28687397
13.

Institutional experience in the treatment of colorectal liver metastases with stereotactic body radiation therapy.

Méndez Romero A, Keskin-Cambay F, van Os RM, Nuyttens JJ, Heijmen BJM, IJzermans JNM, Verhoef C.

Rep Pract Oncol Radiother. 2017 Mar-Apr;22(2):126-131. doi: 10.1016/j.rpor.2016.10.003. Epub 2016 Dec 2.

14.

VMAT plus a few computer-optimized non-coplanar IMRT beams (VMAT+) tested for liver SBRT.

Sharfo AW, Dirkx ML, Breedveld S, Méndez Romero A, Heijmen BJ.

Radiother Oncol. 2017 Apr;123(1):49-56. doi: 10.1016/j.radonc.2017.02.018. Epub 2017 Mar 22.

PMID:
28341061
15.

The role of technology in clinical trials using stereotactic body radiotherapy.

Aznar M, Méndez Romero A, Heijmen BJ.

Br J Radiol. 2017 Mar;90(1071):20160930. doi: 10.1259/bjr.20160930. Epub 2017 Feb 17. Review.

16.

Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care.

Méndez Romero A, de Man RA.

Best Pract Res Clin Gastroenterol. 2016 Aug;30(4):603-16. doi: 10.1016/j.bpg.2016.06.003. Epub 2016 Jun 25. Review.

PMID:
27644908
17.

Identifying at diagnosis the vestibular schwannomas at low risk of growth in a long-term retrospective cohort.

Wolbers JG, Dallenga AH, van Linge A, Te West M, Kummer EE, Méndez Romero A, Pauw BK, Wieringa MH.

Clin Otolaryngol. 2016 Dec;41(6):788-792. doi: 10.1111/coa.12661. Epub 2016 May 11.

PMID:
27086938
18.

Hepatocellular carcinoma: Dutch guideline for surveillance, diagnosis and therapy.

Eskens FA, van Erpecum KJ, de Jong KP, van Delden OM, Klumpen HJ, Verhoef C, Jansen PL, van den Bosch MA, Méndez Romero A, Verheij J, Bloemena E, de Man RA.

Neth J Med. 2014 Jul;72(6):299-304. Review.

19.

Adaptive liver stereotactic body radiation therapy: automated daily plan reoptimization prevents dose delivery degradation caused by anatomy deformations.

Leinders SM, Breedveld S, Méndez Romero A, Schaart D, Seppenwoolde Y, Heijmen BJ.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):1016-21. doi: 10.1016/j.ijrobp.2013.08.009. Epub 2013 Sep 24.

PMID:
24071500
20.

What intervention is best practice for vestibular schwannomas? A systematic review of controlled studies.

Wolbers JG, Dallenga AH, Mendez Romero A, van Linge A.

BMJ Open. 2013 Feb 22;3(2). pii: e001345. doi: 10.1136/bmjopen-2012-001345. Print 2013.

Supplemental Content

Loading ...
Support Center